Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease
Proc Natl Acad Sci U S A
.
2021 Sep 7;118(36):e2106095118.
doi: 10.1073/pnas.2106095118.
Authors
Mira A M Behnam
1
,
Christian D Klein
1
Affiliation
1
Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, 69120 Heidelberg, Germany mira.behnam@uni-heidelberg.de c.klein@uni-heidelberg.de.
PMID:
34475216
PMCID:
PMC8433543
DOI:
10.1073/pnas.2106095118
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Molecular Docking Simulation
Peptide Hydrolases
Protease Inhibitors
SARS-CoV-2*
Substances
Protease Inhibitors
Peptide Hydrolases